相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in brain metabolites related to stress resilience: Metabolomic analysis of the hippocampus in a rat model of depression
Hayato Akimoto et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
Friederike Holze et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C. Mithoefer et al.
PSYCHOPHARMACOLOGY (2019)
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid et al.
PSYCHOPHARMACOLOGY (2018)
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
Patrick C. Dolder et al.
PSYCHOPHARMACOLOGY (2018)
Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects
Patrick C. Dolder et al.
PSYCHOPHARMACOLOGY (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman et al.
FRONTIERS IN PHARMACOLOGY (2018)
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
Michael C. Mithoefer et al.
LANCET PSYCHIATRY (2018)
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Matthias E. Liechti et al.
PSYCHOPHARMACOLOGY (2017)
Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies
Kim P. C. Kuypers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Safety pharmacology of acute MDMA administration in healthy subjects
Patrick Vizeli et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Modern Clinical Research on LSD
Matthias E. Liechti
NEUROPSYCHOPHARMACOLOGY (2017)
Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
Patrick C. Dolder et al.
FRONTIERS IN PHARMACOLOGY (2017)
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
Patrick C. Dolder et al.
CLINICAL PHARMACOKINETICS (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
Anya K. Bershad et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals
Yasmin Schmid et al.
PHARMACOGENETICS AND GENOMICS (2016)
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
R. L. Carhart-Harris et al.
PSYCHOLOGICAL MEDICINE (2016)
Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration
Sunday M. Francis et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Prosocial effects of MDMA: A measure of generosity
Matthew Kirkpatrick et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives
Linda D. Simmler et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination
Cedric M. Hysek et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
C. N. Haile et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Differential effects of MDMA and methylphenidate on social cognition
Yasmin Schmid et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing
Matthew G. Kirkpatrick et al.
NEUROPSYCHOPHARMACOLOGY (2014)
MDMA effects consistent across laboratories
Matthew G. Kirkpatrick et al.
PSYCHOPHARMACOLOGY (2014)
MDMA enhances emotional empathy and prosocial behavior
Cedric M. Hysek et al.
SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)
Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Inattention, impulsive action, and subjective response to D-amphetamine
Jessica Weafer et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
A randomized, controlled pilot study of MDMA (+/- 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)
Peter Oehen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A Receptor
Linnet Ramos et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Prediction of Psilocybin Response in Healthy Volunteers
Erich Studerus et al.
PLOS ONE (2012)
Duloxetine Inhibits Effects of MDMA (Ecstasy) In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study
Cedric M. Hysek et al.
PLOS ONE (2012)
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users
Tibor M. Brunt et al.
PSYCHOPHARMACOLOGY (2012)
Effects of amphetamine on reactivity to emotional stimuli
Margaret C. Wardle et al.
PSYCHOPHARMACOLOGY (2012)
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex
Cedric M. Hysek et al.
PSYCHOPHARMACOLOGY (2012)
The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (Ecstasy) in Humans
C. M. Hysek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Is Ecstasy an Empathogen? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others
Gillinder Bedi et al.
BIOLOGICAL PSYCHIATRY (2010)
Effects of a β-blocker on the cardiovascular response to MDMA (Ecstasy)
C. M. Hysek et al.
EMERGENCY MEDICINE JOURNAL (2010)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration
G. J. H. Dumont et al.
SOCIAL NEUROSCIENCE (2009)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Influence of a Warm Touch Support Enhancement Intervention Among Married Couples on Ambulatory Blood Pressure, Oxytocin, Alpha Amylase, and Cortisol
Julianne Holt-Lunstad et al.
PSYCHOSOMATIC MEDICINE (2008)
A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4-methylenedioxymethamphetamine (ecstasy)
M. R. Thompson et al.
NEUROSCIENCE (2007)
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment
Christopher D. Verrico et al.
PSYCHOPHARMACOLOGY (2007)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo
CE Johanson et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP
M Tancer et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Acute administration of d-amphetamine decreases impulsivity in healthy volunteers
H de Wit et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans
CR Rush et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Psychological and physiological effects of MDMA (ecstasy) after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
ME Liechti et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) are attenuated by the serotonin uptake inhibitor citalopram
ME Liechti et al.
NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
